Iressa
We are engaged in offering Iressa, a targetted therapy. It is classified as a signal transduction inhibitor, epidermal growth factor receptor (EGFR), and tyrosine kinase inhibitor. Iressa is widely used for treating locally advanced or metastatic non-small cell lung cancer, after failure of both platinum-based and taxane-based chemotherapies.
Other Information
-
Pay Mode Terms: L/C (Letter of Credit), D/A (Documents Against Acceptance), D/P (Documents Against Payment), T/T (Bank Transfer), Western Union, Other
Other Information
- Pay Mode Terms: L/C (Letter of Credit), D/A (Documents Against Acceptance), D/P (Documents Against Payment), T/T (Bank Transfer), Western Union, Other
|
